dexamethasone,lenalidomide,bortezomib
takeda
['leukemia', 'mds', 'determination', 'aml,(-streamline),(-seamless),(-kamloops)', 'mmsm']
#asco22 plenery #mmsm determination study
second primary malignancies of interest acute leukemia/mds rvd alone: 7 all, 0 aml, 0 mds (n=7, %=2%) asct: 3 all, 4 aml, 6 mds (n=13, %=3.5%)
no statistical significance 
Assistant professor @UAMSMyeloma. Alumni heme/onc @bcmhouston, clinical research/biostat @UMich.Focus on plasma cell disorders & health disparities. No COI